<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1108222462
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SELECTA 2.5MG F.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        18.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Selecta&trade; contains a medicine called bisoprolol. This belongs to a group of medicines called beta-blockers.<br />These medicines work by affecting the body&rsquo;s response to some nerve impulses, especially in the heart.<br />As a result, Selecta&trade; slows down the heart rate and makes the heart more efficient at pumping blood around<br />the body.<br />Heart failure occurs when the heart muscle is weak and unable to pump enough blood to supply the body&rsquo;s<br />needs. Selecta&trade; is used to treat stable chronic heart failure. They are used in combination with other<br />medicines suitable for this condition (such as ACE inhibitors diuretics and heart glycosides).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Selecta&trade;:<br />Do not take Selecta&trade; if one of the following conditions applies to you:<br />&bull; allergy (hypersensitivity) to bisoprolol fumarate or to any of the other ingredients (see section 6 &lsquo;What<br />Selecta&trade; tablets contain&rsquo;). &bull; severe asthma or severe chronic lung disease.<br />&bull; severe blood circulation problems in your limbs (such as Raynaud&rsquo;s syndrome), which may cause your<br />fingers and toes to tingle or turn pale or blue.<br />&bull; untreated phaeochromocytoma, which is a rare tumour of the adrenal gland.<br />&bull; metabolic acidosis, which is a condition when there is too much acid in the blood.<br />Do not take Selecta&trade; if you have one of the following heart problems:<br />&bull; heart failure that suddenly becomes worse and/or that may require hospital treatment.<br />&bull; slow or irregular heart rate. &bull; very low blood pressure.<br />Take special care with Selecta&trade;<br />If you have any of the following conditions tell your doctor before taking Selecta&trade;; he or she may want to<br />take special care (for example give additional treatment or perform more frequent checks):<br />&bull; diabetes (Selecta&trade; can hide the symptoms of low blood sugar).<br />&bull; strict fasting. &bull; certain heart diseases such as disturbances in heart rhythm, or severe chest pain at rest<br />(Prinzmetal&rsquo;s angina). &bull; kidney or liver problems. &bull; blood circulation problems in your limbs.<br />&bull; asthma or chronic lung disease. &bull; history of a scaly rash (psoriasis).<br />&bull; tumour of the adrenal gland (phaeochromocytoma).<br />&bull; thyroid disorder (Selecta&trade; can hide symptoms of an overactive thyroid).<br />In addition, tell your doctor if you are going to have:<br />&bull; desensitization therapy (for example for the prevention of hay fever), because Selecta&trade; may make it more<br />likely that you experience an allergic reaction, or such reaction may be more severe.<br />&bull; anaesthesia (for example for surgery), because Selecta&trade; may influence how your body reacts to this<br />situation.<br />Taking other medicines<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including<br />medicines obtained without a prescription.<br />Do not take the following medicines with Selecta&trade; without special advice from your doctor:<br />&bull; Certain medicines used to treat irregular or abnormal heartbeat (medicines such as quinidine, disopyramide,<br />lidocaine, phenytoin, flecainide, propafenone).<br />&bull; Certain medicines used to treat high blood pressure, angina pectoris or irregular heartbeat (calcium<br />antagonists such as verapamil and diltiazem).<br />&bull; Certain medicines used to treat high blood pressure such as clonidine, methyldopa, moxonodine,<br />rilmenidine. However, do not stop taking these medicines without checking with your doctor first.<br />Check with your doctor before taking the following medicines with Selecta&trade;; your doctor may need to<br />check your condition more frequently:<br />&bull; Certain medicines used to treat high blood pressure or angina pectoris (felodipine and amlodipine).<br />&bull; Certain medicines used to treat irregular or abnormal heartbeat (medicines such as amiodarone).<br />&bull; Timolol eye drops (and related medicines) for glaucoma treatment.<br />&bull; Certain medicines used to treat for example Alzheimer&rsquo;s disease or glaucoma (such as tacrine or carbachol)<br />or medicines that are used to treat acute heart problems (such as isoprenaline and dobutamine).<br />&bull; Antidiabetic medicines including insulin.<br />&bull; Anaesthetic agents (for example during surgery). &bull; Digoxin, used to treat heart failure.<br />&bull; Non-steroidal anti-inflammatory medicines (NSAIDs) used to treat arthritis, pain or inflammation (for<br />example ibuprofen or diclofenac).<br />&bull; Any medicine, that can lower blood pressure such as antihypertensives, certain medicines for depression<br />(such as imipramine or amitriptyline), certain medicines used to treat epilepsy or during anaesthesia (such as<br />phenobarbital), or certain medicines to treat mental illness (such as levomepromazine).<br />&bull; Mefloquine, used for prevention or treatment of malaria.<br />&bull; Depression treatment medicines called monoamine oxidase inhibitors (except MAO-B inhibitors) such as<br />moclobemide. &bull; Some medicines for migraine (ergotamine derivatives).<br />Pregnancy and breast-feeding<br />There is a risk that use of Selecta&trade; during pregnancy may harm the baby. If you are pregnant or planning to<br />become pregnant, tell your doctor. He or she will decide whether you can take Selecta&trade; during pregnancy.<br />It is not known whether Selecta&trade; passes into human breast milk. Therefore, breastfeeding is not<br />recommended during therapy with Selecta&trade;.<br />Driving and using machines<br />Your ability to drive or use machinery may be affected depending on how well you tolerate the medicine.<br />Please be especially cautious at the start of treatment, when the dose is increased or the medication is<br />changed, as well as in combination with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Selecta&trade; exactly as your doctor has told you. Check with your doctor or pharmacist if you are<br />not sure.<br />Treatment with Selecta&trade; requires regular monitoring by your doctor. This is particularly necessary at the<br />start of treatment and during dose increase.<br />Take the tablet with some water in the morning, with or without food. Do not crush or chew the tablet.<br />Treatment with Selecta&trade; is usually long-term.<br />Adults including the elderly:<br />Treatment with Selecta&trade; must be started at a low dose and increased gradually. Your doctor will decide how<br />to increase the dose, and this will normally be done in the following way:<br />1- (1.25mg) Selecta&trade; once daily for one week. 2- (2.5mg) Selecta&trade; once daily for one week.<br />3- (3.75mg) Selecta&trade; once daily for one week. 4- (5mg) Selecta&trade; once daily for four weeks.<br />6- (7.5mg) Selecta&trade; once daily for four weeks.<br />&bull; 10mg Selecta&trade; once daily for maintenance (on-going) therapy.<br />The maximum recommended daily dose is 10 mg bisoprolol.<br />Depending on how well you tolerate the medicine, your doctor may also decide to lengthen the time between&nbsp;dose increases. If your condition gets worse or you no longer tolerate the drug, it may be necessary to<br />reduce the dose again or to interrupt treatment. In some patients a maintenance dose lower than 10 mg<br />Selecta&trade; may be sufficient. Your doctor will tell you what to do.<br />If you have to stop treatment entirely, your doctor will usually advise you to reduce the dose gradually,<br />as otherwise your condition may become worse.<br />Children: Selecta&trade; is not recommended for use in children.<br />If you take more Selecta&trade; than you should<br />If you have taken more Selecta&trade; than you should, tell your doctor immediately. Your doctor will decide<br />what measures are necessary.<br />Symptoms of an overdose may include dizziness, light-headedness, fatigue, breathlessness and/or<br />wheezing. Also, there may be reduced heart rate, reduced blood pressure, insufficient action of the heart<br />and a low blood glucose level (which may involve feelings of hunger, sweating and palpitations).<br />If you forget to take Selecta&trade;<br />Do not take a double dose to make up for a forgotten dose. Take your usual dose the next morning.<br />If you stop taking Selecta&trade;<br />Never stop taking Selecta&trade; unless on your doctor&rsquo;s advice. Otherwise your condition could become<br />much worse. If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Selecta&trade; can cause side effects, although not everybody gets them.<br />To prevent serious reactions, speak to a doctor immediately if a side effect is severe, occurred suddenly<br />or gets worse rapidly.<br />The most serious side effects are related to the heart function:<br />&bull; Slowing of heart rate (affects more than 1 person in 10).<br />&bull; worsening of heart failure (affects less than 1 person in 10).<br />&bull; slow or irregular heartbeat (affects less than 1 person in 100).<br />If you feel dizzy or weak, or have breathing difficulties please contact your doctor as soon as possible.<br />Further side effects are listed below according to how frequently they may occur:<br />Common: (affects less than 1 person in 10)<br />&bull; tiredness, feeling weak, dizziness, headache.<br />&bull; feeling of coldness or numbness in hands or feet. &bull; low blood pressure.<br />&bull; Stomach or intestine problems such as nausea, vomiting, diarrhoea, or constipation.<br />Uncommon: (affects less than 1 person in 100)<br />&bull; sleep disturbances. &bull; breathing problems in patients with asthma or chronic lung disease.<br />&bull; depression. &bull; muscle weakness, muscle cramps.<br />Rare: (affects less than 1 person in 1,000)<br />&bull; hearing problems. &bull; allergic runny nose. &bull; dry eyes from reduced tear flow (can be troublesome if<br />you use contact lenses). &bull; inflammation of the liver which can cause yellowing of the skin or whites of<br />the eyes. &bull; allergy-like reactions such as itching, flush, rash. &bull; reduced sexual performance (potency<br />disorder). &bull; nightmares, hallucinations. &bull; fainting.<br />Very Rare: (affects less than 1 person in 10, 000)<br />&bull; irritation and redness of the eye (conjunctivitis). &bull; hair loss.<br />&bull; appearance or worsening of scaly skin rash (psoriasis); psoriasis-like rash.<br />Tell your doctor or your pharmacist if you notice any of the side effects listed above or any other<br />unwanted or unexpected effects.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Do not store above 30 &ordm;C. Store in the original package.<br />Do not use Selecta&trade; after the expiry date which is stated on the carton and blister.<br />Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to<br />dispose medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is bisoprolol fumarate. Each tablet contains 2.5mg ، 5mg or 10mg bisoprolol<br />fumarate.<br />- The other ingredients are Colloidal Silicone Dioxide, Crospovidone, Dibasic Calcium Phosphate<br />Anhydrous, Magnesium Stearate, Maize starch, Microcrystalline Cellulose, Opadry white and Purified<br />Water.<br />What Selecta</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Selecta 2.5mg Tablets: White to off-white, round, biconvex, film coated tablets, engraved with 'JP82'
on one side and having break line on the other side.
Selecta 5mg Tablets: White to off-white, round, biconvex, film coated tablets, engraved with 'JP81' on
one side and having break line on the other side.
Selecta 10mg Tablets: White to off-white, round, biconvex, film coated tablets, engraved with 'JP103'
on one side and having break line on the other side.
Selecta™ tablets are availble in 2.5 mg, 5 mg and 10 mg in boxes of 30 tablets each.
Not all packs may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer<br />Jamjoom Pharmaceuticals Co., Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                10-2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="text-align:right">سيليكتا تحتوي&nbsp;على دواء يسمى بايسوبرولول، الذي ينتمى إلى مجموعة من الأدوية تسمى حاصرات بيتا.<br />&nbsp; تعمل هذه الأدوية من خلال التأثير على استجابة الجسم لبعض النبضات العصبية خاصة فى القلب .نتيجة لذلك، سيليكتا&nbsp;<br />يقلل من معدل ضربات القلب و يجعل القلب أكثر كفاءة فى ضخ الدم إلى جميع أنحاء الجسم.<br />قصور القلب يحدث عندما تصبح عضلة القلب ضعيفة و غير قادرة على ضخ ما يكفى من الدم لسد احتياجات الجسم.&nbsp;<br />سيليكتا يستخدم لعلاج ثصور القلب المزمن ويتم استخدام سيليكتا إلى جانب الأدوية الأخرى المناسبة لهذه الحالة مثل (مثبطات الإنزيم المحول &trade; لعلاج قصور القلب المزمن . يتم استخدام سيليكتا<br />للأنجيوتنسين ، مدرات البول و جليكوسيدات القلب).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">لا تتناول سيليكتا&nbsp;إذا كنت تعانى من إحدى الحالات المرضية الآتية:</p><p style="text-align:right">&bull; حساسية مفرطة بايسوبرولول أو أى من المكونات الأخرى لهذا الدواء ( انظر إلى الجزء ر ق م . ٦ م ا ه ي م ك و ن ا ت أ ق ر ا ص س يل ي ك ت ا<br />&bull; ربو حاد أو مرض رئوى مزمن.<br />&bull; مشكلة حادة فى الدورة الدموية فى الأطراف ( مثل متلازمة رينود ) مما يؤدى إلى الشعور بوخز فى أصابع يديك و قدميك أو تصبح<br />شاحبة أو زرقاء اللون.<br />&bull; مرض القواتم و لم تتم معالجته بعد و هو مرض نادر يصيب الغدة الكظرية.<br />&bull; حماض أيضى و هى حالة يزيد فيها تركيز الحمض فى الدم.<br />إذا كنت تعانى من إحدى مشاكل القلب الآتية: &trade; لا تتناول سيليكتا<br />&bull; قصور فى القلب تسوء حالته بصورة مفاجئة و/ أو قد يحتاج إلى العلاج بالمستشفى.<br />&bull; إنخفاض أو عدم انتظام فى معدل ضربات القلب. &bull; إنخفاض شديد فى ضغط الدم.</p><p style="text-align:right">&nbsp;</p><p style="text-align:right">أعط عناية خاصة عند تناول سيليكتا في الحالات التالية:</p><p style="text-align:right">اخبر طبيبك إذا كنت تعانى من إحدى الحالات الآتية، فقد يريد طبيبك أن يعطيك عناية خاصة عن تناولك هذا الدواء على سبيل المثال<br />يمنحك دواء إضافى أو يجرى لك المزيد من الفحوصات الطبية:<br />قد يخفى اعراض إنخفاض السكر بالدم). &bull; الصيام القاسى &bull; داء السكرى<br />&bull; بعض أمراض القلب مثل الإضطراب فى ضربات القلب أو آلام الصدر الحادة التى تحدث أثناء الراحة (ذبحة برنزميتال).<br />&bull; مشاكل فى الكلى أو الكبد. &bull; مشاكل الدورة الدموية فى الأطراف.<br />&bull; ربو أو مرض مزمن فى الرئتين. &bull; تاريخ سابق للإصابة بطفح جلدى قشرى (الصدفية).<br />&bull; ورم فى الغدة الكظرية (ورم القواتم).<br />قد يخفى أعراض مرض فرط نشاط الغدة الدرقية). &bull; إضطراب الغدة الدرقيةا<br />اخبر طبيبك أيضا إذا كنت سوف تتناول الآتى:<br />ذلك لأن سيليكتا قد يزيد من احتمالية إصابتك برد فعل تحسسى أو قد تزيد من حدة الحساسية لديك.</p><p style="text-align:right">عند تخدير ما لإجراء عملية جراحية، ذلك لأن سيليكتا&nbsp;قد يؤثر على كيفية تفاعُل جسمك مع هذه الحالة.</p><p style="text-align:right">تناول أدوية أخرى<br />يرجى إخبار طبيبك أو الصيدلى عن أى أدوية تتناولها حاليا أو تناولتها مؤخرا. هذا يشمل الأدوية التى يمكنك شراؤها بدون تذكرة<br />طبية.</p><p style="text-align:right">لا تتناول الأدوية التالية مع سيليكتا دون استشارة الطبيب.&nbsp;</p><p style="text-align:right">&bull; بعض الأدوية التى تستخدم لعلاج عدم انتظام ضربات القلب مثل كينيدين، ديسوبيراميد، ليدوكايين، فينيتوين، فليكانيد، بروبافينون.<br />&bull; بعض الأدوية التى تستخدم لعلاج ضغط الدم المرتفع ، الذبحة الصدرية أو عدم انتظام ضربات القلب مثل حاصرات الكالسيوم التى<br />تشمل ڤيرابميل، دلتيازيم.<br />&bull; بعض الأدوية التى تستخدم لعلاج ضغط الدم المرتفع مثل كلونيدين، ميثيل دوبا، ريلمينيدين، موكسونودين. لا تتوقف عن استخدام<br />هذه الأدوية قبل أن تستشير طبيبك أولا.</p><p style="text-align:right">تحقق مع طبيبك قبل أن تتناول هذه الأدوية مع سيليكتا&nbsp;قد يحتاج طبيبك أن يفحص حالتك بشكل منتظم :</p><p style="text-align:right">&bull; بعض الأدوية التى تستخدم لعلاج ضغط الدم المرتفع أو الذبحة الصدرية مثل فيلوديبن و أملوديبين.<br />&bull; بعض الأدوية التى تستخدم لعلاج عدم انتظام ضربات القلب مثل أميودارون.<br />&bull; قطرة العين تيمولول و الأدوية المماثلة تستخدم لعلاج ارتفاع ضغط العين (الماء الزرقاء).<br />&bull; بعض الأدوية التى تستخدم لعلاج الزهايمر أو ارتفاع ضغط العين (الماء الزرقاء) مثل تاكرين، و كرباكول أو مشاكل القلب الحادة<br />مثل ايزوبرينالين و دوبوتامين.<br />&bull; الأدوية التى تستخدم لعلاج داء السكرى ومنها الانسولين. &bull; الأدوية المخدرة التى تؤخذ قبل إجراء العمليات الجراحية.<br />&bull; ديجوكسين الذى يستخدم لعلاج قصور القلب.<br />&bull; مضادات الإلتهاب غير الإستيرودية التى تستخدم لعلاج التهاب المفاصل، الألم و الإلتهاب مثل إيبوبروفين و ديكلوفيناك.<br />&bull; الأدوية الخافضة لضغط الدم ، بعض أدوية الإكتئاب مثل إيميبرامين و إيميتربتيلين ، بعض أدوية الصرع مثل فينوباربيتال و بعض<br />أدوية الأمراض العقلية مثل ليفوميبرومازين.<br />&bull; مفلوكين و هو دواء يستخدم للوقاية من و علاج الملاريا.<br />&bull; أدوية علاج الإكتئاب مثل مثبطات إنزيم أوكسيديز أحادى الأمين (باستثناء أوكسيديز أحادى الأمين-ب) مثل موكلوبميد.<br />&bull; بعض أدوية الصداع النصفى مثل مشتقات الإرجوتامين</p><p style="text-align:right">الحمل و الرضاعة<br />أثناء الحمل يمثل خطر على الجنين . يرجى اخبار الطبيب إذا كنتِ حاملاً أو تخططين لأن تكونى حاملا. سوف يقرر &trade; استخدام سيليكتا<br />خلال الحمل. &trade; طبيبك ما إذا كنت تستطيعين تناول سيليكتا<br />ينتقل إلى حليب الثدى البشرى لذلك فلا يوصى بالرضاعة الطبيعية أثناء إستخدامه. &trade; ليس من المعروف ما إذا كان سيليكتا<br />قيادة المركبات و تشغيل الآلات<br />قدرتك على القيادة أو استخدام الآلات يمكن أن تتأثر تبعا كيفية تحملك لهذا الدواء. يرجى توخي الحذر خاصة في بداية العلاج، وعند<br />زيادة الجرعة أو تغيير الدواء، وكذلك في التزامن مع الكحول.</p><p style="text-align:right">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">قم دائما بتناول سيليكتا<br />الاستخدام .<br />يحتاج إلى متابعة منتظمة من طبيبك ، فهذا ضرورى جداً عند بداية العلاج و عند زيادة الجرعة. &trade; العلاج بسيليكتا<br />تناول القرص مع قليل من الماء صباحا مع أو بدون الطعام. لا تقم بسحق أو مضغ القرص.<br />عادة طويل الأمد. &trade; العلاج بسيليكتا<br />الكبار بما فيهم المسنين:<br />يجب أن يبدأ بجرعة صغيرة تزداد تدريجياً. سوف يقرر طبيبك كيف تزداد الجرعة و هذا سوف يتم عادة بالطريقة &trade; العلاج بسيليكتا<br />التالية:<br />۲٫٥ ملجم مرة واحدة يومياً لمدة أسبوع. &trade; ۱٫۲٥ ملجم مرة واحدة يومياً لمدة أسبوع. ۲- سيليكتا &trade; ۱- سيليكتا<br />٥ ملجم مرة واحدة يومياً لمدة ٤ أسابيع. &trade; ۳٫۷٥ ملجم مرة واحدة يومياً لمدة أسبوع. ٤- سيليكتا &trade; ۳- سيليكتا<br />۱۰ ملجم مرة واحدة يومياً كجرعة علاجية مستمرة. &trade; ۷٫٥ ملجم مرة واحدة يومياً لمدة ٤ أسابيع. ٦- سيليكتا &trade; ٥- سيليكتا<br />۱۰ ملجم يومياً. &trade; الجرعة القصوى الموصى بها هى سيليكتا<br />وفقا لمدى تقبلك للعلاج ، من الممكن أن يقرر طبيبك إطالة الوقت بين زيادة الجرعة . إذا تدهورت حالتك أو أصبحت غير متقبل هذا<br />الدواء، فمن الضرورى تقليل الجرعة مرة أخرى أو وقف العلاج . لدى بعض المرضى الجرعة الداعمة قد تقل<br />۱۰ ملجم مرة واحدة يومياً. سوف يخبرك طبيبك بما يجب عليك فعله. &trade; عن سيليكتا<br />إذا وجب عليك وقف العلاج كليا، سوف ينصحك طبيبك بتقليل الجرعة تدريجيا و إلا سوف تتدهور حالتك .<br />للأطفال. &trade; الأطفال: لا ينصح باستخدام سيليكتا.</p><p style="text-align:right">إذا تناولت جرعة زائدة من سيليكتا<br />أعراض الجرعة الزائدة تشمل دوار، تعب، ضيق فى التنفس و أزيز الصدر. قد يحدث أيضا إنخفاض فى معدل ضربات القلب ،<br />إنخفاض ضغط الدم، قصور فى عمل القلب و إنخفاض مستوى السكر فى الدم (يؤدى إلى الشعور بالجوع، التعرق و خفقان القلب).<br />إذا نسيت أن تتناول سيليكتا<br />لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية. خذ جرعتك المعتادة فى صباح اليوم التالى.<br />إذا توقفت عن تناول سيليكتا<br />لا تتوقف أبدا عن تعاطى سيليكتا إلا بعد استشارة طبيبك و إلا سوف تصبح حالتك أكثر سوءا .<br />إذا كانت لديك أى أسئلة أخرى عن هذا الدواء، اسأل طبيبك أو الصيدلى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">كما هو الحال مع جميع الأدوية ، من المحتمل ظهور أعراض جانبية لسيليكتا&nbsp;لكنها لا تصيب كل الأشخاص.</p><p style="text-align:right">لمنع حدوث أعراض جانبية خطيرة ، تحدث إلى طبيبك على الفور إذا كانت الأعراض الجانبية شديدة، حدثت بشكل مفاجىء أو<br />ساءت بشكل سريع.<br />الأعراض الجانبية الأكثر خطورة التى تتعلق بوظائف القلب:<br />&bull; تباطؤ معدل ضربات القلب (يصيب أكثر من ۱ من كل ۱۰ أشخاص يستخدمون هذا الدواء).<br />&bull; تدهور قصور القلب (يصيب أقل من ۱ من كل ۱۰ أشخاص يستخدمون هذا الدواء).<br />&bull; بطء أو عدم انتظام فى ضربات القلب (يصيب أقل من ۱ من كل ۱۰۰ أشخاص يستخدمون هذا الدواء).<br />إذا شعرت بالدوار أو الضعف أو صعوبة فى التنفس يرجى اخبار طبيبك على الفور .<br />المزيد من الآثار الجانبية مدرجة أدناه وفقا لمدى شيوعها:</p><p style="text-align:right">أعراض جانبية شائعة ( تصيب أقل من ۱ من كل ۱۰ أشخاص يستخدمون هذا الدواء)<br />&bull; إرهاق، الشعور بالتعب، دوار، صداع. &bull; الشعور ببرودة أو تنميل فى اليدين أو القدمين.<br />&bull; إنخفاض ضغط الدم. &bull; إضطرابات فى المعدة أو الأمعاء تسبب الغثيان، القىء، الإسهال أو الإمساك.<br />أعراض جانبية غير شائعة ( تصيب أقل من ۱ من كل ۱۰۰ شخص يستخدمون هذا الدواء)<br />&bull; إضطرابات فى النوم. &bull; مشاكل فى التنفس لدى مرضى الربو أو الأشخاص المصابون بمرض مزمن فى الرئتين.<br />&bull; إكتئاب. &bull; ضعف فى العضلات و تشنجات فى العضلات.<br />أعراض جانبية نادرة ( تصيب أقل من ۱ من كل ۱۰۰۰ شخص يستخدمون هذا الدواء)<br />&bull; مشاكل فى السمع. &bull; سيلان الأنف التحسسى.<br />&bull; جفاف العين نتيجة لإنخفاض تدفق الدموع ( من الممكن أن تسبب مشكلة لدى الأشخاص الذين يستخدمون العدسات الاصاقة).<br />&bull; إلتهاب الكبد مما يسبب إصفرار الجلد أو إصفرار بياض العين.<br />&bull; تفاعلات شبه تحسسيه مثل الحكة، الطفح الجلدى و الشعور بالسخونة.<br />&bull; إنخفاض الأداء الجنسى (إضطراب فى القدرة الجنسية). &bull; كوابيس و هلوسة. &bull; فقدان الوعى.<br />أعراض جانبية نادرة جدا ( تصيب أقل من ۱ من كل ۱۰۰۰۰ شخص يستخدمون هذا الدواء)<br />&bull; تهيج و إحمرار فى العينين (التهاب الملتحمة). &bull; فقدان الشعر.<br />&bull; ظهور طفح جلدى قشرى (الصدفية) أو تدهور حالته.<br />يرجى إخبار الطبيب أو الصيدلى إذا لاحظت ظهور أى من الأعراض السابقة أو أى أعراض أخرى غير متوقعة و غير مرغوب<br />فيها.</p><p style="text-align:right">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">يحفظ بعيداً عن متناول و مرأى الأطفال.<br />م. يحفظ داخل العلبة الأصلية. &ordm; يحفظ فى درجة حرارة لا تزيد على ۳۰<br />بعد انتهاء فترة صلاحيتها المكتوب على العلبة. &trade; لا تتناول أقراص سيليكتا<br />اسأل الصيدلي عن طريقة التخلص من الأدوية التي لم تعد بحاجة إليها. لا ينبغي التخلص من الأدوية عبر إلقائها فى بالوعات<br />الصرف أو فى مخلفات المنزل . ستساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">&bull; المادة الفعالة فى أقراص سيليكتا هى بايسوبرولول فيوماريت. كل قرص يحتوي علي ( ۲٫٥ ملجم ، ٥ ملجم أو ۱۰ ملجم). &trade; &bull; المادة الفعالة فى أقراص سيليكتا<br />&bull; المكونات الأخرى تشمل : ثانى أكسيد السيليكون الغروى، كروسبوڤيدون، ثنائي القاعدة فوسفات الكالسيوم لامائي، ستيرات<br />الماغنسيوم، نشا الذرة، سيليلوز دقيق التبلور،أوبادرى أبيض اللون و ماء منقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">أقراص سيليكتا 2.5&nbsp;ملجم لونها أبيض إلي مائل للأبيض، دائرية، محدبة الوجهين، مغلفة، محفور علي جانب واحد`JP82` وعلى الجانب الاخر خط للكسر.</p><p style="text-align:right">أقراص سيليكتا 5&nbsp; ملجم لونها أبيض إلي مائل للأبيض، دائرية، محدبة الوجهين، مغلفة، محفور علي جانب واحد`JP81` وعلى الجانب الاخر خط للكسر.</p><p style="text-align:right">أقراص سيليكتا 10 ملجم لونها أبيض إلي مائل للأبيض، دائرية، محدبة الوجهين، مغلفة، محفور علي جانب واحد `JP103` وعلى الجانب الاخر خط للكسر.</p><p style="text-align:right">قد لا تكون كل العبوات مطروحة بالسوق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">شركة مصنع جمجوم للأدوية، جدة، المملكة العربية السعودية<br />+۹٦٦-۱۲- ۹٦٦ + فاكس: ٦۰۸۱۲۲۲ -۱۲- الهاتف: ٦۰۸۱۱۱۱<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبيه:<br />&bull; المملكة العربية السعودية:<br />- المركز الوطني للتيقظ و السلامة الدوائية<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />للإتصال بالإدارة التنفيذية للتيقظ وإدارة الأزمات.</p><p style="text-align:right">۲۳٤۰-۲۳۳٤-۲۳٥٤-۲۳٥۳-۲۳٥٦- ۹٦٦ +. تحويلة: ۲۳۱۷ -۱۱- هاتف: ۲۰۳۸۲۲۲۲</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            10-2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Selecta 2.5 mg Film Coated Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 2.5 mg Bisoprolol Fumarate.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-Coated Tablets
White to off-white, about 6.0 mm, round biconvex film coated tablets, engraved with 'JP82'
on one side and having break line on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of stable chronic heart failure with reduced systolic left ventricular function in addition<br />to ACE inhibitors, and diuretics, and optionally cardiac glycosides</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Standard treatment of CHF consists of an ACE inhibitor (or an angiotensin receptor blocker in<br />case of intolerance to ACE inhibitors), a beta-blocker, diuretics, and when appropriate cardiac<br />glycosides. Patients should be stable (without acute failure) when bisoprolol treatment is initiated.<br />It is recommended that the treating physician should be experienced in the management of chronic<br />heart failure.</p><p>Transient worsening of heart failure, hypotension, or bradycardia may occur during the titration<br />period and thereafter.<br />Posology:<br />Titration phase<br />The treatment of stable chronic heart failure with bisoprolol requires a titration phase<br />The treatment with bisoprolol is to be started with a gradual uptitration according to the following<br />steps:<br />- 2.5 mg once daily for a further week, if well tolerated increase to<br />- 5 mg once daily for the 4 following weeks, if well tolerated increase to<br />- 10 mg once daily for the maintenance therapy.<br />The maximum recommended dose is 10 mg once daily.<br />Close monitoring of vital signs (heart rate, blood pressure) and symptoms of worsening heart<br />failure is recommended during the titration phase. Symptoms may already occur within the first<br />day after initiating the therapy.<br />Treatment modification<br />If the maximum recommended dose is not well tolerated, gradual dose reduction may be<br />considered.<br />In case of transient worsening of heart failure, hypotension, or bradycardia reconsideration of the&nbsp;dosage of the concomitant medication is recommended. It may also be necessary to temporarily<br />lower the dose of bisoprolol or to consider discontinuation.<br />The reintroduction and/or uptitration of bisoprolol should always be considered when the patient<br />becomes stable again.<br />If discontinuation is considered, gradual dose decrease is recommended, since abrupt withdrawal<br />may lead to acute deterioration of the patients condition.<br />Treatment of stable chronic heart failure with bisoprolol is generally a long-term treatment.<br />Renal or hepatic impairment<br />There is no information regarding pharmacokinetics of bisoprolol in patients with chronic heart<br />failure and with impaired hepatic or renal function. Uptitration of the dose in these populations<br />should therefore be made with additional caution.</p><p>Elderly<br />No dosage adjustment is required.<br />Paediatric population<br />There is no paediatric experience with bisoprolol, therefore its use cannot be recommended in<br />paediatric patients.<br />Method of administration:<br />Bisoprolol tablets should be taken in the morning and can be taken with food. They should be<br />swallowed with liquid and should not be chewed.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bisoprolol is contraindicated in chronic heart failure patients with:• acute heart failure or during episodes of heart failure decompensation requiring i.v. inotropictherapy• cardiogenic shock• second or third degree AV block• sick sinus syndrome• sinoatrial block• symptomatic bradycardia• symptomatic hypotension• severe bronchial asthma or severe chronic obstructive pulmonary disease• severe forms of peripheral arterial occlusive disease or severe forms of Raynaud's syndrome• untreated phaeochromocytoma• metabolic acidosis• hypersensitivity to bisoprolol or to any of the excipients listed in section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The treatment of stable chronic heart failure with bisoprolol has to be initiated with a special<br />titration phase.<br />Especially in patients with ischaemic heart disease the cessation of therapy with bisoprolol must<br />not be done abruptly unless clearly indicated, because this may lead to transitional worsening of<br />heart condition.<br />The initiation and cessation of treatment with bisoprolol necessitates regular monitoring.</p><p>There is no therapeutic experience of bisoprolol treatment of heart failure in patients with the<br />following diseases and conditions:<br />&bull; insulin dependent diabetes mellitus (type I)<br />&bull; severely impaired renal function<br />&bull; severely impaired hepatic function<br />&bull; restrictive cardiomyopathy<br />&bull; congenital heart disease<br />&bull; haemodynamically significant organic valvular disease<br />&bull; myocardial infarction within 3 months<br />Bisoprolol must be used with caution in:<br />&bull; bronchospasm (bronchial asthma, obstructive airways diseases)<br />&bull; diabetes mellitus with large fluctuations in blood glucose values; Symptoms of hypoglycaemia<br />can be masked<br />&bull; strict fasting<br />&bull; ongoing desensitisation therapy. As with other beta-blockers, bisoprolol may increase both the<br />sensitivity towards allergens and the severity of anaphylactic reactions. Epinephrine treatment<br />does not always yield the expected therapeutic effect.<br />&bull; first degree AV block<br />&bull; Prinzmetal&#39;s angina<br />&bull; peripheral arterial occlusive disease. Aggravation of symptoms may occur especially when<br />starting therapy.<br />&bull; general anaesthesia<br />In patients undergoing general anaesthesia beta-blockade reduces the incidence of arrhythmias<br />and myocardial ischemia during induction and intubation, and the post-operative period. It is&nbsp;currently recommended that maintenance beta-blockade be continued peri-operatively. The<br />anaesthesist must be aware of beta-blockade because of the potential for interactions with other<br />drugs, resulting in bradyarrhythmias, attenuation of the reflex tachycardia and the decreased<br />reflex ability to compensate for blood loss. If it is thought necessary to withdraw beta-blocker<br />therapy before surgery, this should be done gradually and completed about 48 hours before<br />anaesthesia.<br />Combination of bisoprolol with calcium antagonists of the verapamil or diltiazem type, with<br />Class I antiarrhythmic drugs and with centrally acting antihypertensive drugs is generally not<br />recommended, for details please refer to section 4.5.<br />In bronchial asthma or other chronic obstructive lung diseases, which may cause symptoms,<br />bronchodilating therapy should be given concomitantly. Occasionally an increase of the airway<br />resistance may occur in patients with asthma, therefore the dose of beta2-stimulants may have to<br />be increased.<br />Patients with psoriasis or with a history of psoriasis should only be given beta-blockers (e.g.<br />bisoprolol) after carefully balancing the benefits against the risks.<br />In patients with phaeochromocytoma bisoprolol must not be administered until after alphareceptor<br />blockade.<br />Under treatment with bisoprolol the symptoms of a thyreotoxicosis may be masked.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Combinations not recommended<br />Calcium antagonists of the verapamil type and to a lesser extent of the diltiazem type: Negative<br />influence on contractility and atrio-ventricular conduction. Intravenous administration of<br />verapamil in patients on &beta;-blocker treatment may lead to profound hypotension and<br />atrioventricular block.<br />Class I antiarrhythmic drugs (e.g. quinidine, disopyramide; lidocaine, phenytoin; flecainide,<br />propafenone): Effect on atrio-ventricular conduction time may be potentiated and negative<br />inotropic effect increased.<br />Centrally acting antihypertensive drugs such as clonidine and others (e.g. methyldopa,<br />moxonodine, rilmenidine): Concomitant use of centrally acting antihypertensive drugs may<br />worsen heart failure by a decrease in the central sympathetic tonus (reduction of heart rate and&nbsp;cardiac output, vasodilation). Abrupt withdrawal, particularly if prior to beta-blocker<br />discontinuation, may increase risk of &ldquo;rebound hypertension&rdquo;.<br />Combinations to be used with caution<br />Calcium antagonists of the dihydropyridine type such as felodipine and amlodipine: Concomitant<br />use may increase the risk of hypotension, and an increase in the risk of a further deterioration of<br />the ventricular pump function in patients with heart failure cannot be excluded.<br />Class-III antiarrhythmic drugs (e.g. amiodarone): Effect on atrio-ventricular conduction time<br />may be potentiated.<br />Topical beta-blockers (e.g. eye drops for glaucoma treatment) may add to the systemic effects of<br />bisoprolol.<br />Parasympathomimetic drugs: Concomitant use may increase atrio-ventricular conduction time<br />and the risk of bradycardia.<br />Insulin and oral antidiabetic drugs: Increase of blood sugar lowering effect. Blockade of betaadrenoreceptors<br />may mask symptoms of hypoglycaemia.<br />Anaesthetic agents: Attenuation of the reflex tachycardia and increase of the risk of hypoglycaemia.&nbsp;</p><p>Anaesthetic agents: Attenuation of the reflex tachycardia and increase of the risk of hypotension<br />(for further information on general anaesthesia.<br />Digitalis glycosides: Reduction of heart rate, increase of atrio-ventricular conduction time.<br />Non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs may reduce the hypotensive effect of<br />bisoprolol.<br />&beta;-Sympathomimetic agents (e.g. isoprenaline, dobutamine): Combination with bisoprolol may<br />reduce the effect of both agents.<br />Sympathomimetics that activate both &beta;- and &alpha;-adrenoceptors (e.g. noradrenaline, adrenaline):<br />Combination with bisoprolol may unmask the &alpha;-adrenoceptor-mediated vasoconstrictor effects<br />of these agents leading to blood pressure increase and exacerbated intermittent claudication.<br />Such interactions are considered to be more likely with nonselective &beta;-blockers.<br />Concomitant use with antihypertensive agents as well as with other drugs with blood pressure<br />lowering potential (e.g. tricyclic antidepressants, barbiturates, phenothiazines) may increase the<br />risk of hypotension.<br />Combinations to be considered&nbsp;</p><p>Mefloquine: increased risk of bradycardia<br />Monoamine oxidase inhibitors (except MAO-B inhibitors): Enhanced hypotensive effect of the<br />beta-blockers but also risk for hypertensive crisis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category C<br />Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy and/or the<br />fetus/newborn. In general, beta-adrenoceptor blockers reduce placental perfusion, which has<br />been associated with growth retardation, intrauterine death, abortion or early labour. Adverse<br />effects (e.g. hypoglycaemia and bradycardia) may occur in the fetus and newborn infant. If<br />treatment with beta-adrenoceptor blockers is necessary, beta1-selective adrenoceptor blockers<br />are preferable.<br />Bisoprolol should not be used during pregnancy unless clearly necessary. If treatment with<br />bisoprolol is considered necessary, the uteroplacental blood flow and the fetal growth should be<br />monitored. In case of harmful effects on pregnancy or the fetus alternative treatment should be<br />considered. The newborn infant must be closely monitored. Symptoms of hypoglycaemia and<br />bradycardia are generally to be expected within the first 3 days.<br />Breast-feeding<br />It is not known whether this drug is excreted in human milk. Therefore, breastfeeding is not<br />recommended during administration of bisoprolol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In a study with coronary heart disease patients bisoprolol did not impair driving performance.<br />However, due to individual variations in reactions to the drug, the ability to drive a vehicle or to<br />operate machinery may be impaired. This should be considered particularly at start of treatment<br />and upon change of medication as well as in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following definitions apply to the frequency terminology used hereafter:<br />Very common (&ge; 1/10)<br />Common (&ge; 1/100, &lt; 1/10)<br />Uncommon (&ge; 1/1,000, &lt; 1/100)<br />Rare (&ge; 1/10,000, &lt; 1/1,000)<br />Very rare (&lt; 1/10,000)<br />Cardiac disorders:<br />Very common: bradycardia.<br />Common: worsening of heart failure.<br />Uncommon: AV-conduction disturbances<br />Investigations:<br />Rare: increased triglycerides, increased liver enzymes (ALAT, ASAT).<br />Nervous system disorders:<br />Common: dizziness, headache.<br />Rare: syncope<br />Eye disorders:<br />Rare: reduced tear flow (to be considered if the patient uses lenses).<br />Very rare: conjunctivitis.</p><p>Ear and labyrinth disorders:<br />Rare: hearing disorders</p><p>Respiratory, thoracic and mediastinal disorders:<br />Uncommon: bronchospasm in patients with bronchial asthma or a history of<br />obstructive airways disease.<br />Rare: allergic rhinitis.<br />Gastrointestinal disorders:<br />Common: gastrointestinal complaints such as nausea, vomiting, diarrhoea, constipation.<br />Skin and subcutaneous tissue disorders:<br />Rare: hypersensitivity reactions (itching, flush, rash).<br />Very rare: alopecia. Beta-blockers may provoke or worsen psoriasis or induce<br />psoriasis-like rash.<br />Musculoskeletal and connective tissue disorders:<br />Uncommon: muscular weakness and cramps.<br />Vascular disorders:<br />Common: feeling of coldness or numbness in the extremities, hypotension.<br />Uncommon: orthostatic hypotension.<br />General disorders:<br />Common: asthenia, fatigue.<br />Hepatobiliary disorders:<br />Rare: hepatitis.<br />Reproductive system and breast disorders:<br />Rare: potency disorders.<br />Psychiatric disorders:<br />Uncommon: sleep disorders, depression.<br />Rare: nightmares, hallucinations.</p><p>&nbsp;</p><p>&nbsp;</p><p>To reports any side effect(s):<br />&bull; Saudi Arabia<br />-The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2340.<br />o Toll free phone: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>With overdose (e.g. daily dose of 15 mg instead of 7.5 mg) third degree AV-block, bradycardia,<br />and dizziness have been reported. In general the most common signs expected with overdosage<br />of a beta-blocker are bradycardia, hypotension, bronchospasm, acute cardiac insufficiency and<br />hypoglycaemia. To date a few cases of overdose (maximum: 2000 mg) with bisoprolol have<br />been reported in patients suffering from hypertension and/or coronary heart disease showing<br />bradycardia and/or hypotension; all patients recovered. There is a wide interindividual variation<br />in sensitivity to one single high dose of bisoprolol and patients with heart failure are probably<br />very sensitive. Therefore it is mandatory to initiate the treatment of these patients with a gradual<br />uptitration according to the scheme given in section 4.2.<br />If overdose occurs, bisoprolol treatment should be stopped and supportive and symptomatic<br />treatment should be provided. Limited data suggest that bisoprolol is hardly dialysable. Based on<br />the expected pharmacologic actions and recommendations for other beta-blockers, the following<br />general measures should be considered when clinically warranted.<br />Bradycardia: Administer intravenous atropine. If the response is inadequate, isoprenaline or<br />another agent with positive chronotropic properties may be given cautiously. Under some<br />circumstances, transvenous pacemaker insertion may be necessary.<br />Hypotension: Intravenous fluids and vasopressors should be administered. Intravenous glucagon<br />may be useful.<br />AV block (second or third degree): Patients should be carefully monitored and treated with<br />isoprenaline infusion or transvenous cardiac pacemaker insertion.<br />Acute worsening of heart failure: Administer i.v. diuretics, inotropic agents, vasodilating agents.</p><p>Bronchospasm: Administer bronchodilator therapy such as isoprenaline, beta2-sympathomimetic<br />drugs and/or aminophylline.<br />Hypoglycaemia: Administer i.v. glucose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Beta blocking agents, selective<br />ATC Code: C07AB07<br />Bisoprolol is a highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating<br />and relevant membrane stabilising activity. It only shows low affinity to the beta2-receptor of the<br />smooth muscles of bronchi and vessels as well as to the beta2-receptors concerned with<br />metabolic regulation. Therefore, bisoprolol is generally not to be expected to influence the<br />airway resistance and beta2-mediated metabolic effects. Its beta1-selectivity extends beyond the<br />therapeutic dose range.<br />In total 2647 patients were included in the CIBIS II trial. 83% (n = 2202) were in NYHA class<br />III and 17% (n = 445) were in NYHA class IV. They had stable symptomatic systolic heart<br />failure (ejection fraction &le;35%, based on echocardiography). Total mortality was reduced from<br />17.3% to 11.8% (relative reduction 34%). A decrease in sudden death (3.6% vs 6.3%, relative<br />reduction 44%) and a reduced number of heart failure episodes requiring hospital admission<br />(12% vs 17.6%, relative reduction 36%) was observed. Finally, a significant improvement of the<br />functional status according to NYHA classification has been shown. During the initiation and<br />titration of bisoprolol hospital admission due to bradycardia (0.53%), hypotension (0.23%), and<br />acute decompensation (4.97%) were observed, but they were not more frequent than in the<br />placebo-group (0%, 0.3% and 6.74%). The numbers of fatal and disabling strokes during the<br />total study period were 20 in the bisoprolol group and 15 in the placebo group.<br />The CIBIS III trial investigated 1010 patients aged &ge;65 years with mild to moderate chronic<br />heart failure (CHF; NYHA class II or III) and left ventricular ejection fraction &le;35%, who had<br />not been treated previously with ACE inhibitors, beta-blockers, or angiotensin receptor blockers.<br />Patients were treated with a combination of bisoprolol and enalapril for 6 to 24 months after an<br />initial 6 months treatment with either bisoprolol or enalapril.</p><p>There was a trend toward higher frequency of chronic heart failure worsening when bisoprolol<br />was used as the initial 6 months treatment. Non inferiority of bisoprolol-first versus enalaprilfirst<br />treatment was not proven in the per-protocol analysis, although the two strategies for<br />initiation of CHF treatment showed a similar rate of the primary combined endpoint death and<br />hospitalization at study end (32.4% in the bisoprolol-first group vs. 33.1 % in the enalapril-first<br />group, per-protocol population). The study shows that bisoprolol can also be used in elderly<br />chronic heart failure patients with mild to moderate disease.<br />Bisoprolol is also used for the treatment of hypertension and angina.<br />In acute administration in patients with coronary heart disease without chronic heart failure<br />bisoprolol reduces the heart rate and stroke volume and thus the cardiac output and oxygen<br />consumption. In chronic administration the initially elevated peripheral resistance decreases.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Bisoprolol is absorbed and has a biological availability of about 90% after oral administration.<br />Distribution<br />The distribution volume is 3.5 l/kg. The plasma protein binding of bisoprolol is about 30%.<br />Biotransformation and Elimination<br />Bisoprolol is excreted from the body by two routes. 50% is metabolised by the liver to inactive<br />metabolites which are then excreted by the kidneys. The remaining 50% is excreted by the<br />kidneys in an unmetabolised form. Total clearance is approximately 15 l/h. The half-life in<br />plasma of 10-12 hours gives a 24 hour effect after dosing once daily.<br />Linearity<br />The kinetics of bisoprolol are linear and independent of age.<br />Special population<br />Since the elimination takes place in the kidneys and the liver to the same extent a dosage<br />adjustment is not required for patients with impaired liver function or renal insufficiency. The&nbsp;pharmacokinetics in patients with stable chronic heart failure and with impaired liver or renal<br />function has not been studied. In patients with chronic heart failure (NYHA stage III) the plasma<br />levels of bisoprolol are higher and the half-life is prolonged compared to healthy volunteers.<br />Maximum plasma concentration at steady state is 64&plusmn;21 ng/ml at a daily dose of 10 mg and the<br />half-life is 17&plusmn;5 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on conventional studies of safety<br />pharmacology, repeated dose toxicity, genotoxicity or carcinogenicity. Like other beta-blockers,<br />bisoprolol caused maternal (decreased food intake and decreased body weight) and embryo/fetal<br />toxicity (increased incidence of resorptions, reduced birth weight of the offspring, retarded<br />physical development) at high doses but was not teratogenic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Maize starch<br />Microcrystalline Cellulose PH 102<br />Crospovidone NF<br />Anhydrous Dibasic Calcium Phosphate<br />Colloidal Silicone Dioxide (Aerosil 200)<br />Magnesium Stearate<br />Opadry White 03H28604<br />Purified Water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 Years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&nbsp;&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Immediate Container: Alu-Alu blister.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company.
P.O. Box 6267
Jeddah 21442
Tel: +966-12-6081111
Fax: +966-12-6081222.
Kingdom of Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sep-2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>